Vaxxinity is a biotechnology business based in the US. Vaxxinity shares (VAXX) are listed on the PINK and all prices are listed in US Dollars. Its last market close was $0.00 – a decrease of 50% over the previous week. Vaxxinity employs 57 staff and has a market cap (total outstanding shares value) of 0.00.
Paid non-client promotion. Finder does not invest money with providers on this page. If a brand is a referral partner, we're paid when you click or tap through to, open an account with or provide your contact information to the provider. Partnerships are not a recommendation for you to invest with any one company. Learn more about how we make money.
Finder is not an advisor or brokerage service. Information on this page is for educational purposes only and not a recommendation to invest with any one company, trade specific stocks or fund specific investments. All editorial opinions are our own.
| Latest market close | $0.00 |
|---|---|
| 52-week range | $0.00 - $1.10 |
| 50-day moving average | $0.01 |
| 200-day moving average | $0.22 |
| Wall St. target price | $15.00 |
| PE ratio | N/A |
| Dividend yield | N/A |
| Earnings per share (TTM) | $-0.45 |
Historical closes compared with the close of $0.0002 from 2024-11-22
| 1 week (2024-11-20) | 0.0002 |
|---|---|
| 1 month (2024-10-25) | -90.00% |
| 3 months (2024-08-27) | -99.60% |
| 6 months (2024-05-24) | -99.75% |
| 1 year (2023-11-27) | -99.98% |
|---|---|
| 2 years (2022-11-25) | -99.99% |
| 3 years (2021-11-26) | 18.46 |
| 5 years (2019-11-23) | N/A |
| Gross profit TTM | $-1,871,000 |
|---|---|
| Return on assets TTM | -48.34% |
| Return on equity TTM | -150.65% |
| Profit margin | 0% |
| Book value | $0.11 |
| Market Capitalization | $25,357 |
TTM: trailing 12 months
We're not expecting Vaxxinity to pay a dividend over the next 12 months.
You may also wish to consider:
Over the last 12 months, Vaxxinity's shares have ranged in value from as little as $0 up to $1.1. A popular way to gauge a stock's volatility is its "beta".
Beta is a measure of a share's volatility in relation to the market. The market (PINK average) beta is 1, while Vaxxinity's is 1.073. This would suggest that Vaxxinity's shares are a little bit more volatile than the average for this exchange and represent, relatively-speaking, a slightly higher risk (but potentially also market-beating returns).
To put Vaxxinity's beta into context you can compare it against those of similar companies.
Vaxxinity, Inc. , a biotechnology company, focuses on developing product candidates for human use in the fields of neurology, cardiovascular diseases, and coronaviruses in the United States. Its product pipeline comprises UB-311, which is in phase 2 clinical trial that targets toxic forms of aggregated amyloid-b in the brain to fight alzheimer's disease; UB-312, which is in phase 1 clinical trial that targets toxic forms of aggregated a-synuclein in the brain to fight parkinson's disease and other synucleinopathies, such as Lewy body dementia and multiple system atrophy; and VXX-301, which is in preclinical trial, an anti-tau product candidate for various neurodegenerative conditions, including alzheimer's disease, traumatic brain injury, and chronic traumatic encephalopathy. It also develops VXX-401, which is phase 1 clinical trial that targets proprotein convertase subtilisin/kexin type 9 serine protease to lower low-density lipoprotein cholesterol and reduce the risk of cardiac events; UB-313 that targets calcitonin gene-related peptide to fight migraines; and UB-612, neutralizes the SARS-CoV-2 virus and is in phase 3 clinical trial. The company was incorporated in 2021 and is headquartered in Merritt Island, Florida. .
Some of the best paper trading apps to practice stock trading with fake money include Interactive Brokers, eToro, Charles Schwab and more.
Want to buy and sell international stocks? Here are the top brokers to help you trade global markets.
These are the best discount brokers of 2024 according to Finder’s comprehensive review.
The best platforms to use for automatic investing include Wealthfront, SoFi, Schwab, Vanguard, Titan, Acorns and more. See our full list here.
We’ve rounded up stats on some of the most popular graphene stocks, along with information on how they compare and how to invest.
5 Betterment robo-advisor alternatives to consider when building your portfolio.
What you need to know about investing in the leading indicator for the overall US stock market.
How do you gift stocks to loved ones? Learn the ins and outs of finding the right investments for them.
Check out the best-performing ETFs so far in 2024.
Acorns is a financial service that rounds up your purchases and turns the extra change into investments.